![Mark Bishop](https://profiles-cardiff.imgix.net/attachments/927?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Mr Mark Bishop
Rheolwr Cymorth Technegol
Ysgol y Biowyddorau
- BishopM@caerdydd.ac.uk
- +44 29206 88512
- Adeilad Hadyn Ellis, Ystafell European Cancer Stem Cell Research Institute, Cardiff School of Biosciences, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff CF24 4HQ, Heol Maendy, Caerdydd, CF24 4HQ
Trosolwyg
Cyhoeddiad
2021
- Hrastelj, J. et al. 2021. CSF-resident CD4+ T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis. Brain Communications (10.1093/braincomms/fcab155)
2005
- Sansom, O. J., Bishop, S. M., Bird, A. and Clarke, A. R. 2005. MBD2 deficiency does not accelerate p53 mediated lymphomagenesis. Oncogene 24(14), pp. 2430-2432. (10.1038/sj.onc.1208166)
2004
- Sansom, O. J., Bishop, S. M., Bird, A. and Clarke, A. R. 2004. MBD4 deficiency does not increase mutation or accelerate tumorigenesis in mice lacking MMR. Oncogene 23(33), pp. 5693-5696. (10.1038/sj.onc.1207767)
2003
- Sansom, O. J., Bishop, S. M., Court, H., Dudley, S., Liskay, R. M. and Clarke, A. R. 2003. Apoptosis and mutation in the murine small intestine: loss of MIh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. DNA Repair 2(9), pp. 1029-1039. (10.1016/S1568-7864(03)00111-3)
- Sansom, O. J., Zabkiewicz, J., Bishop, S. M., Guy, J., Bird, A. and Clarke, A. R. 2003. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene 22(46), pp. 7130-7136. (10.1038/sj.onc.1206850)
- Sansom, O. J., Berger, J., Bishop, S. M., Hendrich, B., Bird, A. and Clarke, A. R. 2003. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nature Genetics 34(2), pp. 145-147. (10.1038/ng1155)
2002
- Millar, C. B. et al. 2002. Enhanced CpG Mutability and Tumorigenesis in MBD4-Deficient Mice. Science, pp. 403-405. (10.1126/science.1073354)
Erthyglau
- Hrastelj, J. et al. 2021. CSF-resident CD4+ T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis. Brain Communications (10.1093/braincomms/fcab155)
- Sansom, O. J., Bishop, S. M., Bird, A. and Clarke, A. R. 2005. MBD2 deficiency does not accelerate p53 mediated lymphomagenesis. Oncogene 24(14), pp. 2430-2432. (10.1038/sj.onc.1208166)
- Sansom, O. J., Bishop, S. M., Bird, A. and Clarke, A. R. 2004. MBD4 deficiency does not increase mutation or accelerate tumorigenesis in mice lacking MMR. Oncogene 23(33), pp. 5693-5696. (10.1038/sj.onc.1207767)
- Sansom, O. J., Bishop, S. M., Court, H., Dudley, S., Liskay, R. M. and Clarke, A. R. 2003. Apoptosis and mutation in the murine small intestine: loss of MIh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. DNA Repair 2(9), pp. 1029-1039. (10.1016/S1568-7864(03)00111-3)
- Sansom, O. J., Zabkiewicz, J., Bishop, S. M., Guy, J., Bird, A. and Clarke, A. R. 2003. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene 22(46), pp. 7130-7136. (10.1038/sj.onc.1206850)
- Sansom, O. J., Berger, J., Bishop, S. M., Hendrich, B., Bird, A. and Clarke, A. R. 2003. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nature Genetics 34(2), pp. 145-147. (10.1038/ng1155)
- Millar, C. B. et al. 2002. Enhanced CpG Mutability and Tumorigenesis in MBD4-Deficient Mice. Science, pp. 403-405. (10.1126/science.1073354)